Medtimes Medical Group

What Medtimes Medical Group does

Medtimes Medical Group (時代醫療集團) is a Hong Kong-based, privately held multi-specialty health examination and preventive-medicine operator running three owned clinics in Central, Tsim Sha Tsui, and Sha Tin. Its core offering is a direct-to-consumer platform of (1) health-check packages priced HK$1,980-HK$8,830 targeted at elderly, men's, women's, prenatal, and corporate segments; (2) adult and pediatric vaccination services including HPV, shingles, pneumococcal, RSV, MMRV, and childhood immunization plans, plus on-site corporate vaccination; and (3) an in-house DNA/genetic testing laboratory menu spanning non-invasive prenatal testing (SafeT21), Y-chromosome and prenatal paternity testing, 23-pathogen stool DNA testing, HPV43 genotyping, hereditary cardiomyopathy (MYH7), thalassemia, 420+ recessive disease screening (HeredScreen, NGS, 99.9% accuracy), and an expanding cancer-risk panel (PROPHECY NPC, non-invasive CRC, hereditary cancer, BRCA1/2). The proprietary technology backbone is next-generation sequencing and advanced molecular diagnostic workflows run inside the company's own registered Hong Kong laboratory, paired with associated non-molecular diagnostics such as FibroScan liver-fibrosis scanning, endoscopy, DEXA bone-density imaging (at two sites), IgE allergy panels, and government-recognized COVID-19 PCR.

Name

Medtimes Medical Group

Legal name

Medtimes Medical Group

Website

https://medtimes.com.hk

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Medtimes Medical Group is a Hong Kong-based private clinic operator running three centers (Central, Tsim Sha Tsui, Sha Tin) offering preventive health check-ups, adult and pediatric vaccinations, on-site corporate vaccination, and an in-house DNA/next-generation-sequencing laboratory delivering NIPT, paternity, hereditary disease, and cancer-risk genetic tests to individual consumers, families, and corporate clients.

Ownership category

akta.pro rank

Product category

Preventive Healthcare and Diagnostic Medical Services

NAICS

Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

akta.pro secondary industry

Immunization & Vaccine Clinics (HLAKAGAJ)

Keywords

• Preventive health screening
• DNA genetic testing
• Vaccination services
• Non-invasive prenatal testing
• Medical examination center

Headquarters

HQ city

Kwai Tsing

HQ country

Hong Kong SAR China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Services and Health Check-ups: Direct consumer provision of comprehensive health check-up plans, vaccination services, and medical examinations billed on a per-service basis. Services include annual health check-ups, specialized check-ups, corporate health plans, and add-on examinations.
2. Genetic Testing Services: DNA and genetic testing services including prenatal testing, maternity Y-chromosome testing, paternity testing, kinship testing, cancer risk screening, and disease gene testing. Revenue generated per test with pricing ranging from HK$5900 for standard prenatal testing to HK$7900 for comprehensive recessive disease screening.
3. Vaccination Services: Preventive vaccination services for both adults and children including HPV, shingles, pneumococcal, influenza, MMR, hepatitis, and pertussis vaccines. Revenue generated per injection or per vaccination course.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Medtimes Medical Group is a Hong Kong-based multi-specialty health examination center providing comprehensive preventive healthcare under one roof. Its core offerings include tiered health check-up plans (annual, specialized, pre-marital, elderly, men's, women's, corporate), adult and pediatric vaccination services, and an extensive DNA/genetic testing menu covering non-invasive prenatal testing, paternity testing, hereditary cancer and recessive disease screening, parasite DNA testing, and HPV genotyping. Supporting services include endoscopy, FibroScan liver assessment, allergy and antibody testing, weight management, and on-site corporate vaccination delivery.

Product overview

Medtimes Medical Group is a multi-specialty health examination center in Hong Kong providing a diversified portfolio of medical services organized across four main categories: (1) Health Check Plans covering annual checkups, specialized examinations (cardio-cerebrovascular, hepatitis B carrier, gastrointestinal cancer, HPV screening), pre-marital screening, elderly health plans (86-92 items), and men's health plans (52 items); (2) Vaccination Services including adult vaccines (HPV, shingles, pneumococcal, RSV, influenza, MMR, pertussis for pregnant women, hepatitis) and comprehensive children's vaccination programs (infant immunization plans, brain protection packages, 6-in-1/5-in-1, Hib, PCV, rotavirus, meningococcal ACWY/B, Japanese encephalitis, MMRV, hepatitis A); (3) DNA/Genetic Testing encompassing non-invasive prenatal testing (SafeT21 Standard/Advanced), maternal blood Y chromosome testing, prenatal and postnatal paternity testing, kinship testing, 23-pathogen stool DNA testing (PSDNA), HPV43 genotyping, nasopharyngeal cancer screening (PROPHECY), non-invasive colorectal cancer testing, hereditary cancer panels, BRCA testing, children's talent and metabolic screening, hereditary cardiomyopathy (MYH7) testing, 420+ recessive genetic disease screening (HeredScreen), and thalassemia testing; and (4) Health Support Services including weight management programs, allergy testing (next-gen IgE, 22PLUS), liver fibrosis scanning (FibroScan), endoscopy (colonoscopy, gastroscopy), antibody testing (HPV, measles, COVID-19 IgG), and on-site vaccination services. The company operates three clinic locations in Central, Tsim Sha Tsui, and Sha Tin, serving the Hong Kong community with online booking and report access capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Health Check (週年健康檢查) Comprehensive annual health examination packages covering basic physical assessment, blood tests, urine analysis, and organ function screening designed for regular health monitoring of adult consumers in Hong Kong.
• Specialized Health Check (專科健康檢查) Targeted health screening packages addressing specific conditions such as cardio-cerebrovascular health, hepatitis B carrier status, gastrointestinal cancer risk, and HPV screening for adult consumers seeking condition-specific assessment.
• Pre-marital Health Check (婚前檢查) Pre-marital health screening designed for couples planning marriage, covering genetic compatibility, infectious diseases, and reproductive health indicators.
• Elderly Health Check Plan (長者安心健康檢查計劃) Health examination packages specifically designed for individuals aged 60 and above, covering cardiovascular assessment, bone density DEXA, cancer markers, and chronic disease management. Available in two tiers: Comprehensive (86 items, HK$1,980) and Premium (91-92 items including cancer markers, cardiac enzyme, DEXA bone scan, HK$2,880). Accepts Hong Kong government healthcare vouchers.
• Men's Health Check Plan (男士檢查計劃) Health screening package tailored for men, including prostate-specific antigen (PSA) testing, upper abdominal and prostate ultrasound, lipid profile, and liver/renal function assessment (52 items, HK$3,300).
• SafeT21 Non-invasive Prenatal Testing (敏兒安) Non-invasive prenatal DNA testing for chromosomal abnormalities using maternal blood. Available in two tiers: Standard (3 trisomies and 7 microdeletion syndromes) and Advanced (22 aneuploidies, 126 microdeletion syndromes, 4 sex chromosome conditions), with results in 5 working days. For expectant parents seeking early and comprehensive prenatal genetic risk assessment.
• Maternal Blood Y-Chromosome Testing (母血Y染色體基因檢測) Prenatal blood test to detect fetal Y chromosome from maternal plasma, with same-day results (Yi, 1 working day) and multi-week options for 5, 6, or 7+ weeks gestation.
• Prenatal Paternity Testing (產前親子鑑定測試) Prenatal parentage verification using maternal blood and suspected father's biological sample (buccal swab, blood, or hair). YPAT test delivers results in 3 working days.
• Parasite and Pathogen Stool DNA Test (PSDNA, 23-plex) (寄生蟲及病原體大便檢測) Advanced stool DNA sequencing test detecting 23 parasites and pathogens including Helicobacter pylori, hepatitis B virus, Cryptosporidium, Giardia, Salmonella, and various helminths. Sensitivity exceeds 99%, with results in 1-2 days (HK$900 promotional price).
• HPV43 Virus Genetic Test (HPV43 病毒基因檢測) DNA-based test for 43 HPV virus strains using high vaginal swab or urine sample. Delivers results in 2 days at HK$760.
• Early Nasopharyngeal Cancer Screening — PROPHECY (早期鼻咽癌篩查) Genetic screening test for early detection of nasopharyngeal carcinoma (NPC) risk, particularly relevant in Southern Chinese populations where NPC incidence is elevated.
• Non-invasive Colorectal Cancer Risk Testing (非入侵性大腸癌風險檢測) Non-invasive DNA-based test assessing colorectal cancer risk without requiring colonoscopy, suitable for consumers seeking convenient screening.
• Hereditary Cancer Genetic Testing (遺傳性癌症基因檢測) Genetic testing panel for hereditary cancer risk assessment covering multiple cancer susceptibility genes, for consumers with family history of cancer.
• Breast & Ovarian Cancer BRCA Genetic Testing (乳癌&卵巢癌BRCA基因檢測) Targeted genetic testing for BRCA1 and BRCA2 mutations associated with elevated breast and ovarian cancer risk, primarily for women with relevant family history.
• MYH7 Hereditary Cardiomyopathy Genetic Testing (遺傳性心肌病基因檢測) Genetic screening test for hereditary cardiomyopathy using buccal swab samples. Delivered in 5 working days at HK$1,200.
• HeredScreen 420+ Recessive Genetic Disease Screening (基康檢隱性遺傳病基因檢測) Comprehensive recessive genetic disease panel covering 420+ conditions using next-generation sequencing (NGS) technology with 99.9% accuracy. Detects silent carriers of spinal muscular atrophy and Fragile X syndrome. Results in 30 working days (HK$7,900).
• Thalassemia Genetic Testing (地中海貧血基因檢測) Genetic screening for thalassemia carriers, particularly relevant in Southern Chinese populations. Available as Type A only (HBADNA, HK$3,200), Type B only (HBBDNA, HK$3,200), or combined A&B (HBDNA, HK$3,800) from 3mL EDTA or buccal swab samples.
• COVID-19 Nucleic Acid Testing (COVID-19 核酸檢測) Government-recognized PCR testing service for SARS-CoV-2 detection, serving travelers and consumers requiring certified COVID-19 test results.
• HPV Vaccination (HPV疫苗注射) Human papillomavirus vaccination for protection against HPV-related cancers and diseases, available for adolescents and adults.
• Shingles/Zoster Vaccination (生蛇疫苗注射) Vaccination against herpes zoster (shingles) for prevention of viral reactivation and postherpetic neuralgia, primarily targeted at older adults.
• Pneumococcal Vaccination (肺炎球菌疫苗注射) Pneumococcal vaccination protecting against Streptococcus pneumoniae infections including pneumonia, meningitis, and sepsis.
• RSV Vaccination (RSV呼吸道合胞病毒疫苗) Vaccination against respiratory syncytial virus (RSV), recommended for older adults and high-risk individuals.
• Influenza Vaccination (流感疫苗注射) Seasonal influenza vaccination for annual flu prevention, available to adults and children.
• MMR Vaccination (MMR麻疹疫苗注射) Combined measles, mumps, and rubella vaccination for protection against three viral diseases, primarily for children and adults needing booster immunization.
• Pertussis Vaccination for Pregnant Women (孕婦百日咳疫苗) Pertussis (whooping cough) vaccination recommended for pregnant women during weeks 12-35 of pregnancy. The vaccine generates maternal antibodies transferred to the fetus via the placenta, providing protection during the vulnerable neonatal window period before the infant completes primary vaccination.
• Children's Vaccination Program (兒童疫苗計劃) Comprehensive pediatric vaccination program including infant immunization plans, brain protection packages, and individual vaccines such as 6-in-1/5-in-1, Hib, PCV, rotavirus, meningococcal ACWY and B, Japanese encephalitis, MMRV, designed for parents seeking structured childhood immunization.
• MMRV Combination Vaccine (四痘混合疫苗) Combined vaccine protecting against measles, mumps, rubella, and varicella (chickenpox) in a single injection. Manufactured by Merck (ProQuad, USA MSD). Two doses recommended at 12 and 15 months, providing 99.8% varicella immune response.
• Children's Hepatitis A Vaccine (兒童甲型肝炎疫苗) Hepatitis A vaccination for children aged 1 and above, manufactured by GSK UK (Havrix 720). Two doses given 6 months apart with approximately 10 years of protection.
• Allergy Testing (過敏測試) Allergy screening services including next-generation IgE allergy testing covering 43 allergens and a 22PLUS comprehensive allergen panel for consumers with suspected allergic conditions.
• Liver Fibrosis Scanning — FibroScan (肝纖維化掃瞄) Non-invasive liver fibrosis assessment using FibroScan technology to measure liver stiffness and steatosis, for patients with hepatitis or fatty liver concerns.
• Endoscopy Services (內視鏡檢查) Diagnostic endoscopy services including colonoscopy and gastroscopy (OGD) for gastrointestinal examination.
• Weight Management Program (體重管理療程) Medically supervised weight management treatment programs for consumers seeking physician-guided weight loss.
• Antibody Testing (抗體測試) Serology testing services including HPV antibody testing, measles antibody testing, and COVID-19 IgG antibody detection for consumers checking post-vaccination or post-infection immunity.
• On-site Vaccination Service (上門疫苗注射服務) Mobile vaccination service bringing vaccine administration to homes, corporate offices, or community locations, for corporate clients, group bookings, and individual consumers unable to visit clinics.

Quantifiable outcome

• 99.9% accuracy for HeredScreen 420+ recessive disease gene testing
• +2 more outcomes

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Healthway Medical: Singapore-headquartered but with Hong Kong presence; operates a network of medical centres offering family medicine, health screening, and vaccinations — comparable service mix and clinic-network model.
• Prenetics: Hong Kong-listed DNA testing company offering NIPT and hereditary cancer panels with similar direct-to-consumer genetic test portfolio; competes most directly on SafeT21-equivalent NIPT and cancer risk screening.
• EC Healthcare: Hong Kong's largest listed medical group spanning multiple specialties and preventive services, including health checks across its clinic network — direct competitor for premium check-up customers.
• Town Health International Medical Group: Hong Kong-listed chain of medical centres offering health screening, general practice, and specialist services with multi-location presence — comparable clinic-based operating model in the same market.
• Quality HealthCare: One of Hong Kong's largest private multi-specialty medical service networks offering health checks, vaccinations, and diagnostics across multiple clinic locations — directly comparable on service breadth and physical footprint.
• Human Health: Hong Kong-based private medical group operating multi-disciplinary clinics offering health checks, vaccinations, and diagnostic services — similar horizontal multi-specialty positioning.

Broad incumbents

• 23andMe: Global direct-to-consumer genetic testing incumbent with broad hereditary disease and cancer risk panels; competes for the same consumer DNA testing wallet, especially among English-speaking and expatriate Hong Kong customers.

Regional players

• MCHC (Modern Health Care): Hong Kong private medical group offering health screening and specialty services; comparable in scope but primarily serves a different segment mix within the same geography.

Others

• Hong Kong Genome Project (HKGP) / Hong Kong Hospital Authority: Public-sector genomics and diagnostic providers in Hong Kong offering subsidized genetic testing; sets the baseline for clinical-grade genetic services and influences regulatory expectations for private labs like Medtimes.

Emerging players

• Sanomics: Hong Kong-based genetic testing lab specializing in liquid biopsy and cancer genomics; competes for the same hereditary cancer and oncology genetic testing customer base, though more B2B/clinician-facing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/MedtimesMedicalGroup
• LinkedInlinkedin.com/company/medtimes-medical-group

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medtimes Medical Group